Clindamycin, capsules 150mg, 16pcs

Composition

1 capsule contains:  

Clindamycin (in the form of hydrochloride) 150 mg.

Auxiliary substances:  

Corn starch,

Lactose monohydrate,

Talcum powder,

Magnesium stearate.

Capsule body composition:  

Dye azorubin (E 122),

Diamond black dye (E 151),

Gelatin.

Capsule cap composition:  

Titanium dioxide (E 171),

Quinoline yellow dye (E 104),

Dye azorubin (E 122),

Crimson dye Ponso 4R (E 124),

Diamond black dye (E 151),

Gelatin.

Pharmacological action

Clindamycin-a drug from the group of antibiotics-lincosamides, has a wide spectrum of action, is bacteriostatic, binds to the 50S subunit of the ribosome and inhibits protein synthesis in microorganisms.

Active in relation to:

– Staphylococcus spp. (including Staphylococcus epidermidis, which produce penicillinase).

– Streptococcus spp. (excluding Enterococcus spp. ).

– Streptococcus pneumoniae.

– Anaerobic and microaerophilic gram-positive cocci (including Peptococcus spp. and Peptostreptococcus spp. ).

– Corynebacterium diphtheriae.

– Clostridium perfringens.

– Clostridium tetani.

– Mycoplasma spp.

– Bacteroidesspp. (including Bacteroides fragilis and Bacteroides melaningenicus).

– Anaerobic gram-positive, non-spore-forming bacilli (including Propionibacterium spp., Eubacterium spp., Actinomyces spp. ).

Most strains of Clostridium perfringens are sensitive to clindamycin, but other clostridium species (Clostridium sporogenes, Clostridium tertium) are resistant to the drug, so an antibiotic chart is recommended for infections caused by Clostridium spp.

By its mechanism of action and antimicrobial spectrum, it is close to lincomycin (it is 2-10 times more active against some types of microorganisms, especially against bacteroids and non-spore-forming anaerobes).

Indications

Infectious and inflammatory diseases caused by clindamycin-sensitive microorganisms:

– Upper respiratory tract infections and ENT infections

– Pharyngitis.

– Tonsillitis.

– Sinusitis.

– Otitis media.

– Pneumonia, including aspiration.

– Lung abscess.

– Empyema of the pleura.

– Bronchitis.

– Chlamydia.

– Endometritis.

– Vaginal infections.

– Tubo-ovarian inflammation.

– Infected wounds.

– Abscesses.

– Boils.

– Panaritius.

– Abdominal cavity:

– Peritonitis.

– Abscess.

Use during pregnancy and lactation

Contraindicated

Contraindications

– Myasthenia gravis.

– Bronchial asthma.

– Ulcerative colitis (in the anamnesis).

– Rare hereditary diseases such as galactose intolerance, lactase deficiency or glucose-galactose malabsorption (for capsules).

– Pregnancy.

– Lactation period.

– Children under 8 years of age for capsules (average child weight less than 25 kg).

– Hypersensitivity.

Use with caution in patients with:

– Severe hepatic and / or renal insufficiency.

– In elderly patients.

Interaction

Clindamycin increases (mutually) the effect of rifampicin, aminoglycosides, streptomycin, gentamicin (especially in the treatment of osteomyelitis and prevention of peritonitis after intestinal perforation).

Enhances the effect of competitive muscle relaxants, and also enhances muscle relaxation caused by n-holinoblockers.

Incompatible with ampicillin, barbiturates, aminophylline, calcium gluconate and magnesium sulfate.

It shows antagonism with erythromycin and chloramphenicol.

Simultaneous use with solutions containing a complex of B vitamins, aminoglycosides, and phenytoin is not recommended.

Concomitant use with antidiarrheal medications increases the risk of pseudomembranous colitis.

When used concomitantly with opioid (narcotic) analgesics, it is possible to increase the respiratory depression caused by them (up to apnea).

How to take, course of use and dosage

-Inside, adults and children over 15 years of age (average child weight 50 kg and above) with moderate diseases are prescribed 1 capsule (150 mg) 4 times/day (every 6 hours).

– For severe infections, adults and children over 15 years of age can increase the single dose to 2-3 capsules (300-450 mg).

– For children from 8 years to 15 years, the method of use of capsules is shown in the table.

For intravenous and intravenous use, the recommended dose is:

– For adults-300 mg 2 times/day. In severe infections – up to 1.2-2.7 g / day, divided into 3-4 injections.

– Children older than 3 years – 15-25 mg / kg / day, divided into 3-4 equal doses. In severe infections, the daily dose can be increased to 25-40 mg / kg of body weight, divided into 3-4 identical injections.

Patients with severe hepatic and / or renal insufficiency do not need to adjust the dosage regimen if the drug is prescribed at intervals of at least 8 hours.

Overdose

-Symptoms: possible increased side effects.

– Treatment: symptomatic therapy, no specific antidote.

Hemodialysis and peritoneal dialysis are ineffective.

Special instructions

– Use in patients with impaired liver function: Clindamycin should be used with caution in patients with severe hepatic insufficiency. Patients should be monitored for liver function (liver enzymes).

– Use in patients with impaired renal function: Clindamycin is used with caution in patients with severe renal insufficiency.

Pseudomembranous colitis can appear both against the background of taking clindamycin, and 2-3 weeks after stopping treatment (3-15% of cases); it is manifested by diarrhea, leukocytosis, fever, abdominal pain (sometimes accompanied by the release of blood and mucus with feces).

If these phenomena occur in mild cases, it is sufficient to cancel treatment and use ion exchange resins ( colestyramine, colestipol), in severe cases, compensation for the loss of fluid, electrolytes and protein, the appointment of vancomycin inside or metronidazole is indicated.

Do not use medications that inhibit intestinal motility.

The safety of using the drug in children under 3 years of age has not been established. With long-term therapy, children need periodic monitoring of blood formula and liver function.

When prescribing the drug in high doses, it is necessary to monitor the concentration of clindamycin in plasma.

Composition

Capsule Form of production

Storage conditions

Store at a temperature of 15-25 °C. Keep out of reach of children. Do not use after the expiration date.

Shelf

life is 3 years.

Active ingredient

Clindamycin

Conditions of release from pharmacies

By prescription

Dosage form

Capsules

Description

Children over 8 years of age, Adults by doctor’s prescription, Children by doctor’s prescription

Indications

Boils, Respiratory tract infections, Skin infections, Pneumonia, Infectious diseases, Pharyngitis, Tonsillitis, Sore throat